Latest news
Neurocrine advances GLP-1/GIP/glucagon triple agonist into first-in-human obesity study - AllSciAllSci · Fri, 07 Aug 2026 16:26:00 GMTBezisterim meets motor and non-motor endpoints in phase II early Parkinson's trial. - AllSciAllSci · Thu, 06 Aug 2026 16:12:09 GMTModerna launches first clinical trial of mRNA vaccine against Bundibugyo ebolavirus strain - AllSciAllSci · Wed, 05 Aug 2026 10:23:59 GMT